Muindi JR - Search Results

1

A phase I pharmacokinetic and pharmacodynamic study of intravenous calcitriol in combination with oral gefitinib in patients with advanced solid tumors.

Fakih MG, Trump DL, Muindi JR, Black JD, Bernardi RJ, Creaven PJ, Schwartz J, Brattain MG, Hutson A, French R, Johnson CS. Fakih MG, et al. Among authors: muindi jr. Clin Cancer Res. 2007 Feb 15;13(4):1216-23. doi: 10.1158/1078-0432.CCR-06-1165. Clin Cancer Res. 2007. PMID: 17317832 Clinical Trial.

2

Anti-tumor activity of calcitriol: pre-clinical and clinical studies.

Trump DL, Hershberger PA, Bernardi RJ, Ahmed S, Muindi J, Fakih M, Yu WD, Johnson CS. Trump DL, et al. J Steroid Biochem Mol Biol. 2004 May;89-90(1-5):519-26. doi: 10.1016/j.jsbmb.2004.03.068. J Steroid Biochem Mol Biol. 2004. PMID: 15225831 Review.

3

Phase II trial of high-dose, intermittent calcitriol (1,25 dihydroxyvitamin D3) and dexamethasone in androgen-independent prostate cancer.

Trump DL, Potter DM, Muindi J, Brufsky A, Johnson CS. Trump DL, et al. Cancer. 2006 May 15;106(10):2136-42. doi: 10.1002/cncr.21890. Cancer. 2006. PMID: 16598750 Free article. Clinical Trial.

4

Vitamin D compounds: clinical development as cancer therapy and prevention agents.

Trump DL, Muindi J, Fakih M, Yu WD, Johnson CS. Trump DL, et al. Anticancer Res. 2006 Jul-Aug;26(4A):2551-6. Anticancer Res. 2006. PMID: 16886663 Free article.

5

Pharmacokinetics of liquid calcitriol formulation in advanced solid tumor patients: comparison with caplet formulation.

Muindi JR, Potter DM, Peng Y, Johnson CS, Trump DL. Muindi JR, et al. Cancer Chemother Pharmacol. 2005 Nov;56(5):492-6. doi: 10.1007/s00280-005-1015-2. Epub 2005 May 26. Cancer Chemother Pharmacol. 2005. PMID: 15918041 Clinical Trial.

6

Monocyte fructose 1,6-bisphosphatase and cytidine deaminase enzyme activities: potential pharmacodynamic measures of calcitriol effects in cancer patients.

Muindi JR, Peng Y, Wilson JW, Johnson CS, Branch RA, Trump DL. Muindi JR, et al. Cancer Chemother Pharmacol. 2007 Jan;59(1):97-104. doi: 10.1007/s00280-006-0247-0. Epub 2006 May 6. Cancer Chemother Pharmacol. 2007. PMID: 16680461 Clinical Trial.

7

The antitumor efficacy of calcitriol: preclinical studies.

Johnson CS, Muindi JR, Hershberger PA, Trump DL. Johnson CS, et al. Among authors: muindi jr. Anticancer Res. 2006 Jul-Aug;26(4A):2543-9. Anticancer Res. 2006. PMID: 16886662 Free article. Review.

8

A phase I and pharmacokinetics study of intravenous calcitriol in combination with oral dexamethasone and gefitinib in patients with advanced solid tumors.

Muindi JR, Johnson CS, Trump DL, Christy R, Engler KL, Fakih MG. Muindi JR, et al. Cancer Chemother Pharmacol. 2009 Dec;65(1):33-40. doi: 10.1007/s00280-009-1000-2. Epub 2009 Apr 26. Cancer Chemother Pharmacol. 2009. PMID: 19396601 Free PMC article. Clinical Trial.

9

A phase I, pharmacokinetic, and pharmacodynamic study of two schedules of vorinostat in combination with 5-fluorouracil and leucovorin in patients with refractory solid tumors.

Fakih MG, Fetterly G, Egorin MJ, Muindi JR, Espinoza-Delgado I, Zwiebel JA, Litwin A, Holleran JL, Wang K, Diasio RB. Fakih MG, et al. Among authors: muindi jr. Clin Cancer Res. 2010 Jul 15;16(14):3786-94. doi: 10.1158/1078-0432.CCR-10-0547. Epub 2010 May 12. Clin Cancer Res. 2010. PMID: 20463088 Free PMC article. Clinical Trial.

10

A Phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancy.

Smith DC, Johnson CS, Freeman CC, Muindi J, Wilson JW, Trump DL. Smith DC, et al. Clin Cancer Res. 1999 Jun;5(6):1339-45. Clin Cancer Res. 1999. PMID: 10389917 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters